Literature DB >> 7976311

Gliosis of the eighth nerve transitional region in patients with cerebellopontine angle schwannoma.

T Matsunaga1, J Kanzaki, Y Hosoda.   

Abstract

The central-peripheral transitional region (TR) of the eighth nerve root was obtained from 8 patients with cerebellopontine angle schwannoma and investigated by light microscopy, electron microscopy, and immunohistochemistry. As a control, the TRs of 6 autopsy patients without any otologic disease were studied. Astrocytic proliferation at the TR was more prominent in the schwannoma patients than in the normal controls. Mild gliosis of the mantle zone of the TR was found in 5 schwannoma patients and moderate gliosis was noted in 3. The distribution of capillaries at the TR differed between the schwannoma patients and the normal controls. In the schwannoma patients, capillaries were rarely found in the mantle zone of the TR but were densely clustered at the glial fringe zone, especially near its border with the peripheral nervous tissue. Stasis of the capillaries in the glial fringe zone was frequently noted. These histological findings may indicate the occurrence of gliosis in response to eighth nerve degeneration. We suggest that there is increased susceptibility of the eighth nerve to injury at the TR in patients with schwannoma.

Entities:  

Mesh:

Year:  1994        PMID: 7976311     DOI: 10.3109/00016489409126076

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Imbalance and dizziness caused by unilateral vestibular schwannomas correlate with vestibulo-ocular reflex precision and bias.

Authors:  Susan King; Kilian Dahlem; Faisal Karmali; Konstantina M Stankovic; D Bradley Welling; Richard F Lewis
Journal:  J Neurophysiol       Date:  2022-01-26       Impact factor: 2.714

2.  Cell Transplantation to Restore Lost Auditory Nerve Function is a Realistic Clinical Opportunity.

Authors:  Tetsuji Sekiya; Matthew C Holley
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.